1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71(3): 209-49.

2. Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ 2012; 344: e2718.

3. Gkantaifi A, Papadopoulos C, Spyropoulou D, Toumpourleka M, Iliadis G, Kardamakis D, et al. Breast Radiotherapy and Early Adverse Cardiac Effects. The Role of Serum Biomarkers and Strain Echocardiography. Anticancer Res 2019; 39(4): 1667-73.

4. Koutroumpakis E, Palaskas NL, Lin SH, Abe, J I, Liao Z, Banchs J, et al. Modern Radiotherapy and Risk of Cardiotoxicity. Chemotherapy 2020; 65(3-4): 65-76.

5. van den Bogaard VA, Ta BD, van der Schaaf A, Bouma AB, Middag AM, Bantema-Joppe EJ, et al. Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures. J Clin Oncol 2017; 35(11): 1171-8.

6. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368(11): 987-98.

7. Michel L, Mincu RI, Mahabadi AA, Settelmeier S, Al-Rashid F, Rassaf T, et al. Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis. Eur J Heart Fail 2020; 22(2): 350-61.

8. Erven K, Florian A, Slagmolen P, Sweldens C, Jurcut R, Wildiers H, et al. Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy. Int J Radiat Oncol Biol Phys 2013; 85(5): 1172-8.

9. Tschakert G, Kroepfl JM, Mueller A, Harpf H, Harpf L, Traninger H, et al. Acute Physiological Responses to Short- and Long-Stage High-Intensity Interval Exercise in Cardiac Rehabilitation: A Pilot Study. J Sports Sci Med 2016; 15(1): 80-91.

10. Dun Y, Smith JR, Liu S, Olson TP. High-Intensity Interval Training in Cardiac Rehabilitation. Clin Geriatr Med 2019; 35(4): 469-87.

11. Garrone O, Crosetto N, Lo Nigro C, Catzeddu T, Vivenza D, Monteverde M, et al. Prediction of anthracycline cardiotoxicity after chemotherapy by biomarkers kinetic analysis. Cardiovasc Toxicol 2012; 12(2): 135-12.

12. Parastesh M, Bayatiani M, Khaleghi M, Sadeghian Shahi M, Ayatizadeh Tafti F, Aria B. The effect of high-intensity interval training on inflammatory markers in male rats undergoing X-ray radiation. J Bas Res Med Sci 2022; 9(1): 10-8.

13. Toohey K, Pumpa K, McKune A, Cooke J, Welvaert M, Northey J, et al. The impact of high-intensity interval training exercise on breast cancer survivors: a pilot study to explore fitness, cardiac regulation and biomarkers of the stress systems. BMC Cancer 2020; 20(1): 787.

14. Mugele H, Freitag N, Wilhelmi J, Yang Y, Cheng S, Bloch W, et al. High-intensity interval training in the therapy and aftercare of cancer patients: a systematic review with meta-analysis. J Cancer Surviv 2019; 13(2): 205-23.

15. Tsuji K, Matsuoka YJ, Ochi E. High-intensity interval training in breast cancer survivors: a systematic review. BMC Cancer 2021; 21(1): 184. Published 2021 Feb 22.

16. Sárközy M, Varga Z, Gáspár R, Szűcs G, Kovács MG, Kovács ZZ, et al. Pathomechanisms and therapeutic opportunities in radiation-induced heart disease: from bench to bedside. Clin Res Cardiol 2021; 110(4): 507-31.

17. Bogdanis GC, Stavrinou P, Fatouros IG, Philippou A, Chatzinikolaou A, Draganidis D, et al. Short-term high-intensity interval exercise training attenuates oxidative stress responses and improves antioxidant status in healthy humans. Food Chem Toxicol 2013; 61: 171-7.

18. Shing CM, Peake JM, Ahern SM, Strobel NA, Wilson G, Jenkins DG, et al. The effect of consecutive days of exercise on markers of oxidative stress. Appl Physiol Nutr Metab 2007; 32(4): 677-85.

19. McDonagh TA, Holmer S, Raymond I, Luchner A, Hildebrant P, Dargie HJ. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail 2004; 6(3): 269-73.

20. Saibene T, Michieletto S, Evangelista L, Bianchi A, Orvieto E, Lora O, et al. Intraoperative radiotherapy during breast cancer surgery: acute and chronic cardiac safety tested by an ultra-sensitive troponin and N-terminal Pro-B-type natriuretic peptide. Eur J Oncol 2014; 19(3): 159-66.

21. Zhang C, Shi D, Yang P. BNP as a potential biomarker for cardiac damage of breast cancer after radiotherapy: a meta-analysis. Medicine (Baltimore) 2019; 98(29): e16507.

22. Portaluri M, Petruzzelli MF, Tramacere F, Andreassi MG. B-type natriuretic peptide plasma level in 5-year breast cancer survivors after radiotherapy. Int J Radiat Biol 2019; 95(2): 201-6.

23. Gomez DR, Yusuf SW, Munsell MF, Welsh JW, Liao Z, Lin SH, et al. Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure. J Thorac Oncol 2014; 9(10): 1554-60.

24. Sawaya H, Sebag IA, Plana JC, Januzzi J L, Ky B, Cohen V, et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol 2011; 107(9):1375-80.

25. Michel L, Mincu RI, Mrotzek SM, Korste S, Neudorf U, Rassaf T, et al. Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis. ESC Heart Fail 2020; 7(2): 423-33.